Nikolay Samusik

Nikolay Samusik is a trailblazer in spatial biology, currently at the helm of Parhelia Biosciences as CEO and co-founder. Dedicated to democratizing advanced biological technologies, Nikolay has transformed complex scientific processes into simple, user-friendly solutions. Starting his career at Stanford University in the Nolan lab. Nikolay developed cutting-edge algorithms for CyTOF data analysis from 2013 to 2019. This work led to CODEX, a groundbreaking platform for high-parameter tissue imaging. Building on CODEX's success, Nikolay co-founded Akoya Biosciences with co-founders Gary Nolan and Yury Goltsev to commercialize this technology. Through strategic leadership, Akoya Biosciences acquired Opal technology from Perkin Elmer, solidifying its role as a leader in spatial biology. In June 2021, they founded Parhelia Bioscience to address critical needs in the scientific community. The company focuses on simplifying staining protocols and reducing reagent costs without sacrificing quality. They aim to make advanced spatial biology technologies accessible and affordable for all researchers. Nikolay's work has revolutionized spatial biology, making high-parameter tissue imaging practical worldwide. His commitment to innovation drives Parhelia Bio's success and influence in the industry.